混凝沉淀+ABR+A/O工艺处理中成药制药废水  

Treatment of Chinese Patent Medicine Wastewater by a Combined Process of Coagulation and Sedimentation,ABR and A/O

作　　者：刘媛 欧阳二明[1] 王乐乐[1] 欧阳佳婷 魏良良 LIU Yuan;OUYANG Er-ming;WANG Le-le;OUYANG Jia-ting;WEI Liang-liang(School of Civil Engineering and Architecture,Nanchang University,Nanchang 330031,China)

机构地区：[1]南昌大学建筑工程学院,江西南昌330031

出　　处：《中国给水排水》2018年第16期97-101,共5页China Water & Wastewater

摘　　要：针对中成药制药废水特性,采用混凝沉淀+ABR+A/O工艺进行处理,对其进出水水质进行长时间监测,结果显示,进水COD、氨氮、总磷含量分别在2 370、45、3. 1 mg/L左右,出水相应指标分别稳定在75、2. 8、0. 5 mg/L左右,综合去除率分别达到96%、93%、83%以上,满足《中药类制药工业水污染物排放标准》(GB 21906—2008)。According to the characteristics of traditional Chinese medicine effluent, a combined process of coagulation and sedimentation, anaerobic baffled reactor and A/O was used to treat the organic wastewater. After monitoring of influent and effluent quality for a long time, the results showed that the removal rates of COD, NH3 -N and TP were 96% , 93% and 83%, respectively, when influent COD, NH3 -N and TP were 2 370 mg/L, 45 mg/L and 3.1 mg/L, respectively. The corresponding effluent COD, NH3 - N and TP were 75 mg/L, 2.8 mg/L and 0.5 mg/L, respectively, which could meet the requirement of Discharge Standard of Water Pollutants for Pharmaceutical Industry Chinese Traditional Medicine Category （ GB 21906 -2008）.

关 键 词：中成药废水 混凝沉淀 ABR A/O 

分 类 号：TU993[建筑科学—市政工程]